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ABSTRACT
Compromised cerebral blood flow (CBF) regulation is linked to impaired functional outcome following
concussion. Cerebral vasoreactivity (CVR), an important mechanism in CBF regulation, is the ability of
cerebral blood vessels to alter blood flow during dynamic changes in arterial carbon-dioxide (CO₂).
PURPOSE: The purpose of this study was to examine CVR in an ongoing prospective cohort of collegiate
athletes during acute (day-3) and sub-acute (day-21) phases following concussion and compare them with
non-injured athletes. METHODS: Sixteen male and female collegiate athletes (21±1 years) with sportsrelated concussion and 16 sports matched non-injured controls (21±1 years) were enrolled in the study. For
injured athletes, data was collected during the acute and sub-acute phase following concussion and for the
controls data was collected at one time point. Symptom severity and cognition were assessed using the
Sports Concussion Assessment Tool-3rd Edition. Continuous middle cerebral artery blood flow velocity
(MCAV) was obtained with transcranial Doppler ultrasonography (TCD) while subjects were seated in an
upright position. End-tidal CO₂ (PetCo₂) was measured with an infrared CO₂ analyzer attached to a nasal
cannula. MCAV was evaluated in response to changes in PetCo₂ for 2-minutes each during normal
breathing (normocapnia), inspiring a gas mixture containing 8% CO₂, 21% oxygen (hypercapnia) and,
hyperventilating (hypocapnia). CVR was analyzed as the slope of the linear relationship between PetCo₂
and MCAV, which was expressed as the percent change in CBF velocity per mmHg change in PetCo₂.
Independent and paired t-tests were used to compare symptom severity, and CVR between acute and subacute phase following concussion with the controls. RESULTS: As anticipated, concussed athletes
exhibited higher symptom severity (26.3±0.5 versus 5±7 P= 0.0007) and lower cognition (26.5±1.6 versus
28.3±2.4 P=0.03) during acute phase compared to the controls. Although symptoms and cognition were
resolved during the sub-acute phase, CVR was lower in the acute phase compared to the non-injured
controls (1.7±0.5U versus 2.3±0.3U, P=0.0006) and it continued to be blunted in the sub-acute phase
following concussion (1.9±0.5U P=0.04). CONCLUSION: Despite improvements in symptom and
cognition, cerebral vasoreactivity appears to be impaired in the sub-acute phase following concussion.
Cerebral vasoreactivity utilizing TCD may be a useful vascular biomarker for physiological recovery and
aid in accurate return-to play decision-making.
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